SEC Form 4 · accession 0001511164-16-001058
Lotus Biotech Development Corp. · LBTD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Zoltan Nagy
Other
Period of report
Oct 1, 2016
Accepted (ET)
Oct 6, 2016 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001520592
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Lotus Bio-Technogy Dev.Corp | Oct 1, 2016 | S | 50,000,000 | $0.001 | D | 0 | I | Ex President/CEO |
Table II — derivative securities
No Table II lines on this filing.